Topical Evaluation

2
Nov

FACT SHEET – InflammaSkin®: Anti-psoriasis efficacy testing for topical & injectable drugs

Home / Resources / Fact Sheets Fact Sheet Anti-psoriasis efficacy testing for topical & injectable drugsExplore InflammaSkin® for anti-psoriatic therapy testing InflammaSkin® is a T cell–driven human skin inflammation model with a Th17/Th1 phenotype, designed to support the evaluation of anti-psoriatic therapies in a human-relevant context. The model can be used with topical, intradermal, or systemic-like treatment approaches and supports
Read more
25
Sep

POSTER – Scalp inflammation with a human hair follicle-preserving model

Home / Resources / Posters Poster Recreating scalp inflammation ex vivo: A human hair follicle-preserving model for immunotoxicological & therapeutic assessment Emeline Pagès1, Emilie Braun1, Mathias Peries1, Oceane Grimaud1, Rached Ismail2, Philippe Mondon3, Jose Ginestar3 and Nicolas Gaudenzio1,5 1Genoskin SAS -  2Research Unit UR4312 CBSA, University of Rouen, Evreux, France - 3Sederma, Le Perray en Yvelines, France - 4CFEB SISLEY,
Read more
31
Jul

ESDR 2026

Conferences & eventsCome & meet our amazing teamGenoskin at the 55th Annual ESDR MeetingAdvancing dermatology research with human relevant ex vivo skin models Genoskin was pleased to participate as an exhibitor (booth #4) in the 55th Annual Meeting of the European Society for Dermatological Research, taking place from September 9–12, 2026, at the Heidelberg Congress Center in Heidelberg, Germany. As
Read more
27
Apr

FACT SHEET – WoundSkin®: Advance your wound healing research

WoundSkin® FactsheetHuman ex vivo skin model to study wound healing & bacterial infectionWoundSkin® Factsheet: Advance Your Wound Healing Research Download the WoundSkin® factsheet to explore how a physiologically relevant, wounded human skin model can support your wound healing and infection research. Built on ex vivo human skin tissue, WoundSkin® preserves the full complexity of native skin, including immune responses, while
Read more
7
Apr

Genoskin at SID 2026

Conferences & eventsCome & meet our amazing teamGenoskin at the SID 83rd Annual MeetingAdvancing dermatology research withex vivo human skin models We were pleased to participate in the SID 83rd Annual Meeting, taking place from May 13-16, 2026, at the Hilton in Chicago, Illinois. As one of the leading events in dermatological research, this meeting brought together experts from academia, industry,
Read more
2
Feb

APPLICATION NOTE – NativeSkin® & UV testing

Explore how NativeSkin® supports ethical, human-relevant, and translational research in UV testing, phototoxicity assessment, and photobiology.